跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,769 条关于
“Castle Hill Capital Partners”
全部
16,769
临床试验
9,423
药物
330
机构
209
资讯
6,807
11个月前
PleoPharma Raises $36M Series B to Advance First-in-Class Cannabis Withdrawal Treatment to Phase 3
3个月前
Oak Hill Bio to Go Public via SPAC Merger, Secures $175 Million to Advance Rugonersen for Angelman Syndrome Through Phase 3
去年
Bluebird Bio Goes Private in $29M Deal with Carlyle and SK Capital Partners
9个月前
GHO Capital Partners Acquires AI-Powered R&D Platform Scientist.com to Accelerate Pharmaceutical Research Efficiency
3个月前
Claret Capital Partners Commits €43M to Inventiva's €130M Financing for Pivotal MASH Phase 3 Trial
去年
Castle Biosciences and SciBase Partner to Develop AI-Powered Atopic Dermatitis Flare Prediction Test
去年
Castle Biosciences' TissueCypher Test Receives New York State Approval for Barrett's Esophagus
去年
Castle Biosciences' Atopic Dermatitis Test Shows Promise in Predicting Treatment Response
9个月前
Castle Biosciences' Gene Expression Tests Show Superior Survival Prediction in Melanoma Patients
上个月
Rose Hill Life Sciences Names Bryan Smith Scientific Advisor as Psilocybin Pipeline Advances
第 1 页,共 681 页
上一页
下一页